PCP instructed patient to got to NEBH for further eval.
Labs notable for Cr 3.2, ALT 76, AST 210.
Physical Exam: Admission Physical Exam: VS: 107/62 HR 106 97% 2 liters RR 16 wt GA: AOx3, NAD morbidly obese HEENT: PERRLA.
DTRs 2+ BL (biceps, achilles, patellar).
Discharge Physical Exam: Vitals: 98.2, BP 137/97, HR 86, 100% SaO2 RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, no JVP, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, obese, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis.
Single view shows no evidence of pneumonia, vascular congestion, or pleural effusion.
LABORATORY: [**2161-8-17**] 07:54PM BLOOD Type-ART pO2-77* pCO2-32* pH-7.34* calTCO2-18* Base XS--7 [**2161-8-17**] 07:54PM BLOOD Lactate-1.4 [**2161-8-17**] 06:00PM BLOOD ASA-NEG Ethanol-10 Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG .
[**2161-8-19**] 04:55AM BLOOD WBC-8.7 RBC-4.69 Hgb-13.9* Hct-39.4* MCV-84 MCH-29.6 MCHC-35.3* RDW-15.3 Plt Ct-146* [**2161-8-18**] 05:05PM BLOOD WBC-13.8* RBC-4.89 Hgb-14.4 Hct-40.4 MCV-83 MCH-29.5 MCHC-35.7* RDW-15.4 Plt Ct-134* [**2161-8-18**] 05:52AM BLOOD WBC-16.8* RBC-5.39 Hgb-15.7 Hct-44.7 MCV-83 MCH-29.2 MCHC-35.2* RDW-15.5 Plt Ct-140* [**2161-8-17**] 09:22PM BLOOD WBC-13.8* RBC-5.43 Hgb-16.0 Hct-45.1 MCV-83 MCH-29.4 MCHC-35.4* RDW-15.6* Plt Ct-149* [**2161-8-17**] 06:00PM BLOOD WBC-12.4* RBC-6.13 Hgb-17.8 Hct-50.8 MCV-83 MCH-29.1 MCHC-35.1* RDW-15.9* Plt Ct-169 .
[**2161-8-19**] 04:55AM BLOOD Neuts-77.5* Lymphs-15.3* Monos-5.4 Eos-1.4 Baso-0.4 [**2161-8-18**] 05:52AM BLOOD Neuts-91* Bands-7* Lymphs-1* Monos-1* Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2161-8-17**] 06:00PM BLOOD Neuts-88* Bands-0 Lymphs-8* Monos-4 Eos-0 Baso-0 .
[**2161-8-18**] 05:52AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL .
[**2161-8-19**] 04:55AM BLOOD PT-11.9 PTT-26.0 INR(PT)-1.0 [**2161-8-18**] 05:52AM BLOOD PT-11.9 PTT-27.8 INR(PT)-1.0 [**2161-8-17**] 09:22PM BLOOD PT-13.4 PTT-28.6 INR(PT)-1.1 [**2161-8-17**] 06:49PM BLOOD PT-13.6* PTT-28.0 INR(PT)-1.2* [**2161-8-17**] 06:49PM BLOOD PT-13.6* PTT-28.0 INR(PT)-1.2* .
[**2161-8-17**] 09:22PM BLOOD Fibrino-498* .
[**2161-8-19**] 04:55AM BLOOD Glucose-99 UreaN-27* Creat-1.0 Na-137 K-3.4 Cl-105 HCO3-23 AnGap-12 [**2161-8-18**] 05:05PM BLOOD Glucose-99 UreaN-31* Creat-1.2 Na-138 K-3.4 Cl-107 HCO3-21* AnGap-13 [**2161-8-18**] 05:52AM BLOOD Glucose-116* UreaN-36* Creat-1.5* Na-140 K-3.4 Cl-107 HCO3-19* AnGap-17 [**2161-8-17**] 09:22PM BLOOD Glucose-127* UreaN-42* Creat-2.3* Na-140 K-3.6 Cl-108 HCO3-17* AnGap-19 [**2161-8-17**] 06:00PM BLOOD Glucose-129* UreaN-44* Creat-2.9*# Na-141 K-3.7 Cl-103 HCO3-18* AnGap-24* .
[**2161-8-19**] 04:55AM BLOOD ALT-179* AST-217* AlkPhos-99 TotBili-0.5 [**2161-8-18**] 05:05PM BLOOD ALT-113* AST-160* CK(CPK)-521* AlkPhos-118 TotBili-0.5 [**2161-8-18**] 05:52AM BLOOD ALT-90* AST-146* CK(CPK)-580* AlkPhos-137* TotBili-0.5 [**2161-8-17**] 09:22PM BLOOD ALT-88* AST-150* AlkPhos-160* TotBili-0.5 [**2161-8-17**] 06:00PM BLOOD ALT-100* AST-175* AlkPhos-214* TotBili-0.5 .
[**2161-8-18**] 05:05PM BLOOD CK-MB-3 cTropnT-<0.01 [**2161-8-18**] 05:52AM BLOOD cTropnT-<0.01 [**2161-8-17**] 06:00PM BLOOD cTropnT-<0.01 .
[**2161-8-19**] 04:55AM BLOOD Calcium-8.4 Phos-2.0* Mg-2.4 [**2161-8-18**] 05:05PM BLOOD Calcium-8.0* Phos-1.6* Mg-2.4 [**2161-8-18**] 05:52AM BLOOD Calcium-7.2* Phos-2.1* Mg-2.4 [**2161-8-17**] 09:22PM BLOOD Albumin-3.8 Calcium-7.1* Phos-2.4* Mg-1.1*  Brief Hospital Course:  # Colchicine Toxicity: Anion-gap metabolic acidosis, Leukocytosis, Thrombocytopenia, Transaminitis, Acute Kidney Injury .
Patient was closely observed for signs of GI bleed, cardiotoxicity, liver and kidney failure.
Patients electrolyte abnormalities resolved and myocardial pathology was ruled out.
Patient was counciled on further weight loss, avoidance of high protein foods, and avoidance of alcohol.
Allopurinol  Oral 5.
****It is very important for your PCP to check repeat LFTs and a CBC to monitor the resolving effects of the colchicine toxicity.
[**Last Name (STitle) **] ADDRESS: [**Last Name (NamePattern1) 14648**], [**Location (un) 86**], [**Numeric Identifier 8542**] PHONE: [**Telephone/Fax (1) 26838**]    Completed by:[**2161-8-20**
